The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
AIM: The aim of the study was to compare the functional and structural properties of the motor protein, myosin, and isolated myocyte contractility in heart muscle excised from hypertrophic cardiomyopathy patients by surgical myectomy with explanted failing heart and non-failing donor heart muscle. METHODS: Myosin was isolated and studied using an in vitro motility assay. The distribution of myosin light chain-1 isoforms was measured by two-dimensional electrophoresis. Myosin light chain-2 phosphorylation was measured by sodium dodecyl sulphate-polyacrylamide gel electrophoresis using Pro-Q Diamond phosphoprotein stain. RESULTS: The fraction of actin filaments moving when powered by myectomy myosin was 21% less than with donor myosin (P = 0.006), whereas the sliding speed was not different (0.310 +/- 0.034 for myectomy myosin vs. 0.305 +/- 0.019 microm/s for donor myosin in six paired experiments). Failing heart myosin showed 18% reduced motility. One myectomy myosin sample produced a consistently higher sliding speed than donor heart myosin and was identified with a disease-causing heavy chain mutation (V606M). In myectomy myosin, the level of atrial light chain-1 relative to ventricular light chain-1 was 20 +/- 5% compared with 11 +/- 5% in donor heart myosin and the level of myosin light chain-2 phosphorylation was decreased by 30-45%. Isolated cardiomyocytes showed reduced contraction amplitude (1.61 +/- 0.25 vs. 3.58 +/- 0.40%) and reduced relaxation rates compared with donor myocytes (TT(50%) = 0.32 +/- 0.09 vs. 0.17 +/- 0.02 s). CONCLUSION: Contractility in myectomy samples resembles the hypocontractile phenotype found in end-stage failing heart muscle irrespective of the primary stimulus, and this phenotype is not a direct effect of the hypertrophy-inducing mutation. The presence of a myosin heavy chain mutation causing hypertrophic cardiomyopathy can be predicted from a simple functional assay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Marston and coworkers found twice as much MLC-1a, on average, in a small cohort of HCM tissues (n = 3) compared to donor tissues, using two-dimensional electrophoresis (2DE) and sypro ruby staining (37).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,279
Oxidative stress and redox signalling in cardiac hypertrophy and heart failure
Seddon, M., Looi, Y. H., & Shah, A. M. (2007) · Heart · doi:10.1136/hrt.2005.068270 · Cited by 479
Elliott, P. M., Gimeno, J. R., Tomé, M. T., Shah, J., Ward, D., Thaman, R., Mogensen, J., & McKenna, W. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl041 · Cited by 427 · cited 1×
“LVOTO is associated with an increased risk of sudden death and therefore justifies intervention.(14) The surgical septal myectomy operation removes 3–7 g of myocardium from the interventricular septum in the region of the obstruction(15,16) and the excised muscle is a unique source of human heart muscle with hypertrop…”
BackgroundSelf-citationMyosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy
Van Driest, S. L., Vasile, V. C., Ommen, S. R., Will, M. L., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.045 · Cited by 424
[33] Assays for actin sliding movement over myosin-coated surfaces
Kron, S. J., Toyoshima, Y. Y., Uyeda, T. Q. P., & Spudich, J. A. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)96035-p · Cited by 402 · cited 1×
“38 mm/s at 308C was somewhat lower than previous measurements with human heart myosin,(8,24) however we made measurements in 50 mmol/L KCl and used silica-coated glass rather than the more usual nitrocelluose surface.(25,26) We found a pattern of abnormality in all the myectomy myosin samples; the fraction of filament…”
MethodMorrow, A. G., Reitz, B. A., Epstein, S. E., Henry, W. L., Conkle, D. M., Itscoitz, S. B., & Redwood, D. R. (1975) · Circulation · doi:10.1161/01.cir.52.1.88 · Cited by 395
Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology
Steinberg, T. H., Agnew, B. J., Gee, K. R., Leung, W., Goodman, T., Schulenberg, B., Hendrickson, J., Beechem, J. M., Haugland, R. P., & Patton, W. F. (2003) · PROTEOMICS · doi:10.1002/pmic.200300434 · Cited by 380 · cited 1×
“One-dimensional SDS–PAGE gels were used to analyse the levels of phosphorylation using the Pro-Q Diamond stain developed by Molecular Probes (Invitrogen).(20) Myofibrils or myosin (10–20 mg) was separated on 10 12 cm gels (8–18% Polyacrylamide gradient, 1% SDS: Exelgel, GE Biosciences).”
MethodVANDERVELDEN, J., PAPP, Z., ZAREMBA, R., BOONTJE, N., DEJONG, J., OWEN, V, BURTON, P., GOLDMANN, P., JAQUET, K., & STIENEN, G. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00606-5 · Cited by 301
Davies, C. H., Davia, K., Bennett, J. G., Pepper, J. R., Poole-Wilson, P. A., & Harding, S. E. (1995) · Circulation · doi:10.1161/01.cir.92.9.2540 · Cited by 208 · cited 1×
“Myocytes were isolated from fresh myectomy or transplant tissue and analysed as described previously.(21) Detailed protocols are provided in the Supplementary material.”
MethodSelf-citationVan Driest, S. L., Jaeger, M. A., Ommen, S. R., Will, M. L., Gersh, B. J., Tajik, A. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.039 · Cited by 194
Tardiff, J. C., Factor, S. M., Tompkins, B. D., Hewett, T. E., Palmer, B. M., Moore, R. L., Schwartz, S., Robbins, J., & Leinwand, L. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2389 · Cited by 193
Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy
Redwood, C. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00213-8 · Cited by 183
Messer, A. E., Jacques, A. M., & Marston, S. B. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.017 · Cited by 177 · cited 3×
“Clinical and functional characteristics of these donor and failing heart samples have been previously reported.(17)”
BackgroundMethodResultInfluentialSelf-citationFiroozi, S. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3285 · Cited by 177
El-Armouche, A., Pohlmann, L., Schlossarek, S., Starbatty, J., Yeh, Y.-H., Nattel, S., Dobrev, D., Eschenhagen, T., & Carrier, L. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.05.003 · Cited by 169 · cited 1×
“The level of MyBP-C phosphorylation is reduced about 50% in myectomy muscle(32) and a similarly reduced level of phosphorylation has been observed in failing heart.(33) We have also observed a low level of MyBP-C and troponin I phosphorylation in both failing heart(17,31) and myectomy muscle samples.”
BackgroundTransgenic Modeling of a Cardiac Troponin I Mutation Linked to Familial Hypertrophic Cardiomyopathy
James, J., Zhang, Y., Osinska, H., Sanbe, A., Klevitsky, R., Hewett, T. E., & Robbins, J. (2000) · Circulation Research · doi:10.1161/01.res.87.9.805 · Cited by 153
VANDERVELDEN, J., PAPP, Z., BOONTJE, N., ZAREMBA, R., DEJONG, J., JANSSEN, P., HASENFUSS, G., & STIENEN, G. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00662-4 · Cited by 147
Regulation of human heart contractility by essential myosin light chain isoforms.
Morano, M., Zacharzowsky, U. B., Maier, M., Lange, P., Alexi-Meskishvili, V. V., Haase, H., & Morano, I. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118813 · Cited by 141
Palmiter, K. A., Tyska, M. J., Haeberle, J. R., Alpert, N. R., Fananapazir, L., & Warshaw, D. M. (2000) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1005678905119 · Cited by 131
Coirault, C., Guellich, A., Barbry, T., Samuel, J. L., Riou, B., & Lecarpentier, Y. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00438.2006 · Cited by 131 · cited 1×
“In support of this idea, it has been shown that motility and ATPase is reduced when skeletal or smooth muscle myosin is oxidized in vitro.(38,39) Clinically, all the HOCM patients had diastolic dysfunction, but ejection fraction was usually not compromised.”
MethodRobinson, P., Mirza, M., Knott, A., Abdulrazzak, H., Willott, R., Marston, S., Watkins, H., & Redwood, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203446200 · Cited by 130 · cited 2×
“Both these properties are characteristic of mutations that cause hypertrophic cardiomyopathy in a variety of contractile proteins that have been studied at the single filament level.(5,6) A higher rate of crossbridge turnover has been recognized as a feature of the few known MHC mutations that have been studied in mus…”
BackgroundResultSelf-citationMorano, I. L., Hädicke, K., Haase, H., Böhm, M., Erdmann, E., & SCHAUB, M. C. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0353 · Cited by 125 · cited 1×
“Immobiline strips (GE Biosciences), and by SDS–PAGE in the second dimension.(19) The gels were stained with SYPRO Ruby (Invitrogen).”
MethodIn Vitro Motility Analysis of Actin-Tropomyosin Regulation by Troponin and Calcium
Fraser, I. D. C., & Marston, S. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.7836 · Cited by 113
Self-citationCardiac Myosin Isoforms from Different Species Have Unique Enzymatic and Mechanical Properties
Malmqvist, U. P., Aronshtam, A., & Lowey, S. (2004) · Biochemistry · doi:10.1021/bi0495329 · Cited by 102 · cited 1×
“Relaxation times for myocytes from failing heart shown here were similar to those previously described from this laboratory, where relaxation times were significantly longer than those for non-failing hearts.(24) At 4 mmol/L Ca2þ, the amplitude difference between myectomy and failing myocytes was reduced (% shortening…”
ResultAshrafian, H., & Watkins, H. C. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.073 · Cited by 101
Self-citationMutation of the myosin converter domain alters cross-bridge elasticity
Köhler, J., Winkler, G., Schulte, I., Scholz, T., McKenna, W. J., Brenner, B., & Kraft, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062415899 · Cited by 86 · cited 1×
“Very few investigations have been made with heart muscle from patients with hypertrophic cardiomyopathy.(8,12,13) The main reason for this has been the unavailability of suitable material.”
BackgroundSelf-citationAbnormal Action Potential Conduction in Isolated Human Hypertrophied Left Ventricular Myocardium
McINTYRE, H., & Fry, C. H. (1997) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1997.tb00850.x · Cited by 85
Redwood, C., Lohmann, K., Bing, W., Esposito, G. M., Elliott, K., Abdulrazzak, H., Knott, A., Purcell, I., Marston, S., & Watkins, H. (2000) · Circulation Research · doi:10.1161/01.res.86.11.1146 · Cited by 75
Self-citationThick Filament Proteins and Performance in Human Heart Failure
Palmer, B. M. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-5249-1 · Cited by 70
Knollmann, B. C., & Potter, J. D. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00115-3 · Cited by 59 · cited 1×
“Both these properties are characteristic of mutations that cause hypertrophic cardiomyopathy in a variety of contractile proteins that have been studied at the single filament level.(5,6) A higher rate of crossbridge turnover has been recognized as a feature of the few known MHC mutations that have been studied in mus…”
BackgroundKirschner, S. E., Becker, E., Antognozzi, M., Kubis, H.-P., Francino, A., Navarro-López, F., Bit-Avragim, N., Perrot, A., Mirrakhimov, M. M., Osterziel, K.-J., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00686.2004 · Cited by 57
Self-citationMyosin from failing and non-failing human ventricles exhibit similar contractile properties
Noguchi, T., Camp, P., Alix, S. L., Gorga, J. A., Begin, K. J., Leavitt, B. J., Ittleman, F. P., Alpert, N. R., Winter, M. M. L., & VanBuren, P. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(02)00282-1 · Cited by 53 · cited 2×
“We did not examine the amount of a and bMHC isoforms present, however an investigation by Noguchi et al.(36) showed that the in vitro motility sliding speed was not different in failing and donor heart myosin despite a variation of the proportion of aMHC from 0 to 13%.”
ResultKnott, A., Purcell, I. F., & Marston, S. B. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.1528 · Cited by 46
Self-citationBing, W., Fraser, I. D. C., & Marston, S. B. (1997) · Biochemical Journal · doi:10.1042/bj3270335 · Cited by 43
Self-citationMarston, S. B. (2003) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1026097313020 · Cited by 23 · cited 1×
“38 mm/s at 308C was somewhat lower than previous measurements with human heart myosin,(8,24) however we made measurements in 50 mmol/L KCl and used silica-coated glass rather than the more usual nitrocelluose surface.(25,26) We found a pattern of abnormality in all the myectomy myosin samples; the fraction of filament…”
MethodSelf-citationH2O2-induced Kinetic and Chemical Modifications of Smooth Muscle Myosin
Penheiter, A. R., Bogoger, M., Ellison, P. A., Oswald, B. J., Perkins, W. J., Jones, K. A., & Cremo, C. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609499200 · Cited by 8
Jacques, A. M., Messer, A. E., Tsang, V. T., McKenna, W. J., & Marston, S. B. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.03.067 · Cited by 5 · cited 1×
“We have also observed a low level of MyBP-C and troponin I phosphorylation in both failing heart(17,31) and myectomy muscle samples.(34) An increase in ALC-1 content in ventricular myosin from less than 5% in donor heart to 2–27% in hypertrophic and failing heart muscle has been reported,(27,35) comparable with our fi…”
ResultSelf-citationYamazaki, T., Suzuki, J., Shimamoto, R., Tsuji, T., Ohmoto, Y., Toyo‐oka, T., Omata, M., Ohtomo, K., & Nagai, R. (2006) · International Heart Journal · doi:10.1536/ihj.47.247 · Cited by 5 · cited 1×
“It is possible that the dysfunction in the interventricular septum, from which our myectomy samples were taken, is not representative of muscle in the rest of the heart.(40) The defining feature of HOCM is a high pressure difference between the aorta and ventricle due to LVOTO caused by septal hypertrophy, therefore i…”
BackgroundGray, R. P., Dhillon, P. S., Jacques, A., Peters, N. S., Walker, J. M., McIntyre, H., McKenna, W. J., & Fry, C. H. (2005) · UCL Discovery (University College London) · Cited by 2
Self-citationXXXVIth European Muscle Conference of the European Society for Muscle Research
Toniolo, L., Canato, M., Nori, A., et al. (2007) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-008-9127-z
Cited by
Lyon, A. R., MacLeod, K. T., Zhang, Y., Garcia, E., Kanda, G. K., Lab, M. J., Korchev, Y. E., Harding, S. E., & Gorelik, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809777106 · Cited by 369
“We have recently demonstrated that these share the slow contraction and relaxation kinetics that characterize end-stage failing human heart (31).”
BackgroundSelf-citationMarston, S., Copeland, O., Jacques, A., Livesey, K., Tsang, V., McKenna, W. J., Jalilzadeh, S., Carballo, S., Redwood, C., & Watkins, H. (2009) · Circulation Research · doi:10.1161/circresaha.109.202440 · Cited by 238
Self-citationFunctions of myosin light chain-2 (MYL2) in cardiac muscle and disease
Sheikh, F., Lyon, R. C., & Chen, J. (2015) · Gene · doi:10.1016/j.gene.2015.06.027 · Cited by 172
“…has also been reported in human patients carrying a rare form of familial hypertrophic cardiomyopathy (FHC) that impacts cardiac papillary muscle and adjacent ventricular muscle, based on specific MLC2v and MLCK mutations (Szczesna et al., 2001; Davis et al., 2001; Jacques et al., 2008).”
BackgroundMyosin light chains: Teaching old dogs new tricks
Heissler, S. M., & Sellers, J. R. (2014) · BioArchitecture · doi:10.1080/19490992.2015.1054092 · Cited by 140
“RLC phosphorylation is reduced in hypertrophic hearts.(116,117) Interestingly, overexpression of the skeletal muscle MLCK gene in mouse cardiac tissue attenuates the isopreternol-induced hypertrophy.”
BackgroundHow Do Mutations in Contractile Proteins Cause the Primary Familial Cardiomyopathies?
Marston, S. B. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9266-2 · Cited by 126
Self-citation
Metadata
- Authors
- Jacques, A. M., Briceno, N., Messer, A. E., Gallon, C. E., Jalilzadeh, S., Garcia, E., Kikonda-Kanda, G., Goddard, J., Harding, S. E., Watkins, H., Esteban, M. T., Tsang, V. T., McKenna, W. J., & Marston, S. B.
- Affiliations
- Imperial College London (GB)
- John Radcliffe Hospital (GB)
- University College London (GB)
- Corresponding author
- Marston, Steven B.
- ORCID
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-14
- Volume
- 79
- Issue
- 3
- Pages
- 481-491
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC2492731
- OpenAlex
- W2074688769
- Cited by
- 43
- References
- 40
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2018: 2 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Cardiovascular Research (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research
- British Heart Foundation (RG/07/012/24110)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- hypertrophic obstructive cardiomyopathy, cardiac myosin, myosin light chain 2 phosphorylation, cardiomyocyte contractility, myectomy, heart failure, myosin motility, molecular phenotypes
- MeSH terms
- Adult, Cardiomyopathy, Hypertrophic, Genotype, Heart Failure, Humans, Actin Cytoskeleton, Middle Aged, Muscle Contraction, Mutation, Phenotype, Phosphorylation, Myosin Light Chains, Myosin Heavy Chains, Cardiac Myosins, Myocytes, Cardiac, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.